Barbara Alexander, MD, MHS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    HealthTrackRx
    Topic:
    Diagnostic Laboratory
    Date added:
    04/04/2022
    Date updated:
    06/28/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Scynexis
    Topic:
    Antifungal Therapy
    Date added:
    04/04/2022
    Date updated:
    06/28/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    F2G
    Topic:
    Antifungal Therapy
    Date added:
    04/04/2022
    Date updated:
    06/28/2024
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Shire/Takeda
    Topic:
    Antiviral Therapy
    Date added:
    04/04/2022
    Date updated:
    06/28/2024
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Cidara
    Topic:
    Antifungal Therapy
    Date added:
    04/04/2022
    Date updated:
    06/28/2024
Return to 2022 Infectious Disease Board Review Course